Results 41 to 50 of about 267,252 (342)

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez, Anna Felip‐Badia, Marina Caballero‐Bellon, Nazaret Sanchez‐Sierra, Alicia Castañeda, Moira Garraus, Maite Gorostegui, Margarida Simão‐Rafael, Juan Pablo Muñoz, Marta Perez‐Somarriba, Salvador Mañe, Mariana Cecilia Planells, Sara Perez‐Jaume, Jaume Mora   +13 more
wiley   +1 more source

AutoML identification of microRNA biomarkers in high-risk pediatric acute lymphoblastic leukemia

Non-coding RNA Research
Despite significant advancements in overall survival rates for childhood acute lymphoblastic leukemia (ALL), relapse continues to pose a major challenge.
Ioannis Kyriakidis, Zacharias Papadovasilakis, Georgios Papoutsoglou, Iordanis Pelagiadis, Helen A. Papadaki, Charalampos Pontikoglou, Eftichia Stiakaki   +6 more
doaj   +1 more source

A Case of a Bilateral Giant Bullous Emphysema: Autologous Blood Application for Air Leak

Southern Clinics of Istanbul Eurasia, 2020
Surgery is a treatment choice in the presence of a giant emphysematous bulla (GBE) that covers at least one third of a hemithorax. In this article, a 53-year-old male patient who presented with complaints of progressive shortness of breath, sputum, and ...
Tevrat Özalp
doaj   +1 more source

Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background We describe clinical and biologic characteristics of neuroblastoma in older children, adolescents, and young adults (OCAYA); describe survival outcomes in the post‐immunotherapy era; and identify if there is an age cut‐off that best discriminates outcomes.
Rebecca J. Deyell, Kavitha Srivatsa, Paola Angelini, Pei‐Chi Kao, Brady Payne, Arlene Naranjo, Sveva Castelli, Miho Kato, Miki Ohira, Ulriche Pöetschger, Yaël Mossé, Lucas Moreno, Meredith S. Irwin, Ramya Ramanujachar, Wendy B. London   +14 more
wiley   +1 more source

Autotransfusão de pré-coleta imediata

Revista do Colégio Brasileiro de Cirurgiões
The practice of auto-transfusion is highly considered due to its safety and economic beneficts. It comprises two basic modalities: "Reinfusion" and "Pre-Collection" of blood.
Levão Bogossian, Aníbal da Torre Bogossian   +1 more
doaj   +1 more source

CHANGES PROTEIN SPECTRUM OF BLOOD PLASMA, WHICH DEVELOP IN PATIENTS WITH CHRONIC HEPATITIS C AFTER AUTOHAEMOTHERAPY

Медицинский вестник Юга России, 2015
Purpose: to study in patients with chronic hepatitis C the pathogenesis hematopoietic activities of autologous blood hemolysate.Materials and methods: we made an indirect MALD-TOF-mass spectrometry of blood plasma in 37 patients with chronic hepatitis C ...
D. V. Dontcov, E. F. Shin, Yu. M. Ambalov, S. V. Mordanov   +3 more
doaj   +1 more source

Organoids in pediatric cancer research

FEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Transfusão autóloga: dois anos de aplicação no serviço de imuno-hemoterapia do Hospital de Santa Maria.

Acta Médica Portuguesa, 1991
The results of a presurgical autologous blood transfusion program for two years are analysed. 1,709 patients were submitted to this program, but appraisable results were only obtained in 1,473. In 39.54% of these ones only autologous blood was used; 19.2%
R Fleming, F Nascimento, A S Madahil
doaj   +1 more source

Surgeons' disposition on the use of autologous blood transfusion in tertiary hospitals in Enugu, Nigeria

Nigerian Journal of Medicine, 2022
Background: The need for autologous blood transfusion in our tertiary hospitals to restore patients' hemodynamics with little or no complications cannot be overemphasized.
Uche Sebastine Ozioko, Emmanuel Chino Iyidobi, Ignatius Ikemefuna Ozor, Ifeanacho Ezeteonu Abireh, Onyinye Mary Ozioko, Chisom Ogbonnaya Mbaeze, Prince Chukwuemeka Okolo   +6 more
doaj   +1 more source

Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial [PDF]

, 2011
Background: Asthma is increasing worldwide and results from a complex immunological interaction between genetic susceptibility and environmental factors. Autovaccination with E.
AE Wright, American Thoracic Society, B Okrasinska-Cholewa, Bianca Weigand, E Zaluga, H Renz, J Halasa, J Halasa, J Kleine-Tebbe, J Rubisz-Brzezinska, Johannes Schulze, K Wilczynski, KJ Drachenberg, M Martin, Markus A Rose, MJ Abramson, NM Berezhnaia, O Nolte, PM Kay, R Schubert, Ralf Schubert, Stefan Zielen, T Zielinski, V Rusch, VF Filatov, Z Novotny   +25 more
core   +3 more sources